Study of plaque production holds promise of helping improve treatment for Alzheimer’s, say investigators. Focusing on the form of the disease found in early onset Alzheimer’s, in the 2 percent of patients who develop the progressive dementia before age 65, researcher now “can examine amyloid beta secretion at the single-cell level, and better understand the responses of individual cells to drugs.”